Billionaires Bill Gates and Jeff Bezos are betting on the New York-based Synchron as the answer to Elon Musk’s Neuralink.
Founded by Australian professors Tom Oxley and Nick Opie, the company on Dec. 16 announced it had closed a $110 million Series C funding round involving Bezos Expeditions, Gates Frontier, and ARCH Venture Partners.
The Synchron Switch is a “brain-computer interface” that is implanted in the blood vessels at the surface of the motor cortex of the brain via the jugular vein.
Once set, the interface will detect and wirelessly transmit information from the brain, allowing severely paralysed individuals to control personal devices without needing to use their hands.
The funds will be put towards a pivotal clinical trial.